ישראל -
עברית -
Ministry of Health
אוטרוגסטן 200
cts ltd - progesterone micronized - קפסולות - progesterone micronized 200 mg - progesterone - progesterone - vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indication, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy. vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).
ישראל -
עברית -
Ministry of Health
אוטרוגסטן 200
cts ltd - progesterone micronized - קפסולות - progesterone micronized 200 mg - progesterone
ישראל -
עברית -
Ministry of Health
טריקאן 200 מג קפסולות
pfizer pfe pharmaceuticals israel ltd - fluconazole - קפסולות - fluconazole 200 mg - fluconazole - fluconazole - cryptococcosis. systemic candidiasis. mucosal candidiasis. vaginal candidiasis.
ישראל -
עברית -
Ministry of Health
ויפנד 200 מג אבקה להכנת תמיסה לעירוי
pfizer pfe pharmaceuticals israel ltd - voriconazole - אבקה להכנת תמיסה לאינפוזיה - voriconazole 200 mg/vial - voriconazole - voriconazole - treatment of :- invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.
ישראל -
עברית -
Ministry of Health
הומלוג קוויק פן 200 יח'מל
eli lilly israel ltd, israel - insulin lispro - תמיסה להזרקה - insulin lispro 200 u/ml - insulin lispro
ישראל -
עברית -
Ministry of Health
סקטרל 200
sanofi - aventis israel ltd - acebutolol as hydrochloride 200 mg - film coated tablets - acebutolol - reduction of hypertension and antiarrhythmic
ישראל -
עברית -
Ministry of Health
דיפלוקאן 200 מ"ג/5 מ"ל
pfizer pharmaceuticals israel ltd - fluconazole 200 mg / 5 ml - powder for suspension - fluconazole - cryptoccosis including cryptoccocal meningitis, systemic candidiasis including candidemia, mucosal candidiasis, vaginal candidiasis, dermatomycosis all as specified in leaflet.
ישראל -
עברית -
Ministry of Health
ויפנד 200 מ"ג אבקה להזרקה
pfizer pharmaceuticals israel ltd - voriconazole 200 mg/vial - powder for solution for infusion - voriconazole - treatment of : - invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei), - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.
ישראל -
עברית -
Ministry of Health
גמזר 200 מג
eli lilly israel ltd - gemcitabine as hydrochloride - אבקה מיובשת בהקפאה להכנת תרכיז לאינפוזיה - gemcitabine as hydrochloride 200 mg/vial - pyrimidine analogues - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.